Literature DB >> 15108351

Expression of Nox4 in osteoclasts.

Su Yang1, Yizhong Zhang, William Ries, Lyndon Key.   

Abstract

A new superoxide-generating enzyme, NADPH oxidase 4 (Nox4), contributes to osteoclastic superoxide production. In this study, we demonstrated that Nox4 is expressed at a higher level in osteoclasts than that in precursor cells. This result suggested that Nox4 is upregulated during the differentiation and development of osteoclasts. Cotransfection of Nox4/P22 DNA resulted in enhanced superoxide production in osteoclasts, indicating that P22 may be a necessary factor for the Nox4 activity. In addition, expression of both cathepsin K and TRAP is increased significantly in osteoclasts cotransfected with Nox4/P22. Further study revealed that JNK was activated and that NF-kappa B was inhibited in Nox4/P22 cotransfected osteoclasts. These findings suggest that superoxide and/or superoxide derived molecules may modulate the signal transduction pathways necessary for osteoclasts to function. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108351     DOI: 10.1002/jcb.20048

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  33 in total

1.  Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells.

Authors:  Howard E Boudreau; Benjamin W Casterline; Balazs Rada; Agnieszka Korzeniowska; Thomas L Leto
Journal:  Free Radic Biol Med       Date:  2012-06-19       Impact factor: 7.376

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

3.  Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling.

Authors:  Md Mizanur Rahman; Amina El Jamali; Ganesh V Halade; Allal Ouhtit; Haissam Abou-Saleh; Gianfranco Pintus
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

4.  NOX4 Deletion in Male Mice Exacerbates the Effect of Ethanol on Trabecular Bone and Osteoblastogenesis.

Authors:  James Watt; Alexander W Alund; Casey F Pulliam; Kelly E Mercer; Larry J Suva; Jin-Ran Chen; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2018-04-13       Impact factor: 4.030

Review 5.  NOX enzymes and Toll-like receptor signaling.

Authors:  Eric Ogier-Denis; Sanae Ben Mkaddem; Alain Vandewalle
Journal:  Semin Immunopathol       Date:  2008-05-21       Impact factor: 9.623

Review 6.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

7.  Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells.

Authors:  Akina Omori; Yoshitaka Yoshimura; Yoshiaki Deyama; Kuniaki Suzuki
Journal:  Biomed Rep       Date:  2015-04-17

8.  Increased oxidative stress in obesity and its impact on metabolic syndrome.

Authors:  Shigetada Furukawa; Takuya Fujita; Michio Shimabukuro; Masanori Iwaki; Yukio Yamada; Yoshimitsu Nakajima; Osamu Nakayama; Makoto Makishima; Morihiro Matsuda; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 10.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.